Journal article
Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis
Abstract
BACKGROUND: The risk of second primary malignancies (SPMs) associated with cancer therapies is an important concern of thyroid cancer survivors and physicians. Our objective was to determine if the risk of SPMs is increased in individuals with thyroid cancer treated with radioactive iodine (RAI), compared to those not treated with RAI.
METHODS: We performed a systematic review of the literature and meta-analysis. Two independent reviewers …
Authors
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Journal
Thyroid, Vol. 19, No. 5, pp. 451–457
Publisher
Mary Ann Liebert
Publication Date
May 2009
DOI
10.1089/thy.2008.0392
ISSN
1050-7256